181 related articles for article (PubMed ID: 14616807)
1. The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome.
Micali G; Lacarrubba F; Nasca MR; De Pasquale R
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():19-23. PubMed ID: 14616807
[TBL] [Abstract][Full Text] [Related]
2. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
Kagy MK; Amonette R
Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes.
Quatresooz P; Piérard GE
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():27-9. PubMed ID: 14616809
[TBL] [Abstract][Full Text] [Related]
4. Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients.
Bianchi L; Costanzo A; Campione E; Nisticò S; Chimenti S
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():24-6. PubMed ID: 14616808
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
6. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
[TBL] [Abstract][Full Text] [Related]
7. Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream.
Mirza B; De'Ambrosis B
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():16-8. PubMed ID: 14616806
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod.
Stockfleth E; Ulrich C; Hauschild A; Lischner S; Meyer T; Christophers E
Eur J Dermatol; 2002; 12(6):569-72. PubMed ID: 12459530
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
[TBL] [Abstract][Full Text] [Related]
10. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.
Weisberg NK; Varghese M
Dermatol Surg; 2002 Jun; 28(6):518-23. PubMed ID: 12081683
[TBL] [Abstract][Full Text] [Related]
12. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
13. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum.
Roseeuw D
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():30-2. PubMed ID: 14616810
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study.
Geisse JK; Rich P; Pandya A; Gross K; Andres K; Ginkel A; Owens M
J Am Acad Dermatol; 2002 Sep; 47(3):390-8. PubMed ID: 12196749
[TBL] [Abstract][Full Text] [Related]
16. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
Madan V; Loncaster JA; Allan D; Lear JT; Sheridan L; Leach C; Allan E
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S86-9. PubMed ID: 17052541
[TBL] [Abstract][Full Text] [Related]
17. Gorlin's syndrome with a thin corpus callosum and a third ventricular cyst.
Kantarci M; Ertas U; Alper F; Sutbeyaz Y; Karasen RM; Onbas O
Neuroradiology; 2003 Jun; 45(6):390-2. PubMed ID: 12756507
[TBL] [Abstract][Full Text] [Related]
18. Superficial basal cell carcinoma on face treated with 5% imiquimod cream.
Malhotra AK; Bansal A; Mridha AR; Khaitan BK; Verma KK
Indian J Dermatol Venereol Leprol; 2006; 72(5):373-5. PubMed ID: 17050935
[TBL] [Abstract][Full Text] [Related]
19. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
Cowen E; Mercurio MG; Gaspari AA
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
[TBL] [Abstract][Full Text] [Related]
20. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
Giannotti B; Vanzi L; Difonzo EM; Pimpinelli N
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():33-5. PubMed ID: 14616811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
